Heinrich Kovar
海因里希·科瓦尔
PhD
Professor; Head, Ewing Sarcoma Research Program教授；尤文肉瘤研究项目负责人
👥Biography 个人简介
Heinrich Kovar is a world-renowned molecular biologist and leading authority on the biology of Ewing sarcoma at the St. Anna Children's Cancer Research Institute in Vienna. His laboratory has produced seminal discoveries about the EWSR1-FLI1 and other EWS-ETS fusion transcription factors that drive Ewing sarcoma, including their transcriptional targets, epigenetic reprogramming activities, and dependence on a permissive neural crest cell of origin. His work underpins current and emerging therapeutic strategies targeting this fusion oncoprotein.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
EWS-FLI1 Transcriptional Oncogenesis
Delineated the transcriptional program controlled by EWS-FLI1, identifying key downstream targets including NKX2.2, NR0B1 (DAX1), and the GLI-VEGFA axis, providing mechanistic understanding of how this fusion protein drives oncogenesis and potential therapeutic vulnerabilities.
Cell of Origin and Epigenetic Reprogramming in Ewing Sarcoma
Demonstrated that EWS-FLI1 functions as an epigenetic reprogrammer that rewires enhancer landscapes in mesenchymal stem cells to recapitulate a neural crest-like gene expression program, establishing the molecular basis for Ewing sarcoma cell identity.
IGF1R Signaling in Ewing Sarcoma
Identified insulin-like growth factor 1 receptor (IGF1R) as a critical survival signal downstream of EWS-FLI1 in Ewing sarcoma, providing preclinical rationale that led to multiple clinical trials of IGF1R antibodies in this disease.
Representative Works 代表性著作
EWS-FLI1 Modulates miRNA-145 and SOX2 Expression to Initiate Mesenchymal Stem Cell Reprogramming toward Ewing Sarcoma
Nature Cell Biology (2012)
Landmark study demonstrating EWS-FLI1-driven epigenetic reprogramming of mesenchymal stem cells as a model for Ewing sarcoma initiation.
The EWSR1-FLI1 Oncogene Drives Formation of Ewing Sarcoma through Reprogramming of Mesenchymal Progenitor Cells
Cancer Cell (2018)
Mechanistic study establishing how the EWS-FLI1 fusion drives cellular transformation through enhancer reprogramming.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Faisal Mahmood
Brigham and Women's Hospital; Harvard Medical School
Kun-Hsing Yu
Harvard Medical School; Brigham and Women's Hospital
Ziad Obermeyer
University of California, Berkeley; UC San Francisco
Andrew H. Beck
PathAI; Harvard Medical School (formerly)
关注 海因里希·科瓦尔 的研究动态
Follow Heinrich Kovar's research updates
留下邮箱，当我们发布与 Heinrich Kovar（St. Anna Children's Cancer Research Institute (CCRI) / Medical University Vienna）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment